Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
COGT · NASDAQ · Pharmaceutical Preparations
$26.72−1.02 (−3.70%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Cogent Biosciences (COGT) · oqro.io/stocks/COGT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office disclosed a new position in COGT for Q3 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Polar Capital Holdings Plc disclosed a new position in COGT for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Aug 14, 2026
Weiss Asset Management LP disclosed a new position in COGT for Q1 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deerfield Management Company, L.P. disclosed a reduced position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed an increased position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Longaeva Partners L.P. no longer reported COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Weiss Asset Management LP no longer reported COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
RTW Investments, LP disclosed a reduced position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Lord, Abbett & Co. LLC disclosed an increased position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Kennedy Capital Management LLC disclosed a reduced position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed an increased position in COGT for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Candriam S.C.A. disclosed an increased position in COGT for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Duquesne Family Office no longer reported COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. disclosed a new position in COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
RTW Investments, LP disclosed a reduced position in COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in COGT for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 30, 2026
Candriam S.C.A. disclosed an increased position in COGT for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Duquesne Family Office disclosed an increased position in COGT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP disclosed an increased position in COGT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a new position in COGT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP no longer reported COGT for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Duquesne Family Office disclosed a new position in COGT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
RTW Investments, LP disclosed a new position in COGT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in COGT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in COGT for Q3 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in COGT for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in COGT for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Siren, L.L.C. disclosed a new position in COGT for Q2 2025SourceInsider trade · Traded Jul 10, 2025 · Filed Jul 14, 2025
Director purchased ~$25M of COGT shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in COGT for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in COGT for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deerfield Management Company, L.P. disclosed a reduced position in COGT for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed an increased position in COGT for Q3 2024SourcePolitician trade (House) · Transaction Dec 12, 2022 · Disclosed Jan 20, 2023
Disclosed purchase of COGT — reported range $1,001 - $15,000SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Lord, Abbett & Co. LLC disclosed an increased position in COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in COGT for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
Kennedy Capital Management LLC disclosed an increased position in COGT for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a new position in COGT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a reduced position in COGT for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Kennedy Capital Management LLC disclosed a reduced position in COGT for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. no longer reported COGT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Siren, L.L.C. disclosed an increased position in COGT for Q3 2025Source